Syndax Pharmaceuticals

New York

280 Total Employees

View Website

What's It Like to Work at Syndax Pharmaceuticals?

Updated on September 09, 2026

This page summarizes recurring themes identified from responses generated by popular LLMs to common candidate questions about Syndax Pharmaceuticals and has not been reviewed or approved by Syndax Pharmaceuticals.

What's it like to work at Syndax Pharmaceuticals?

Strengths in mission clarity, growth opportunity, and competitive rewards are accompanied by a demanding pace, variable mid-level leadership communication, and frequent change typical of commercialization. Together, these dynamics suggest a high-impact environment that suits builders comfortable with intensity and evolving structures while others may experience strain.

Key Insight for Candidates

Commercial-launch momentum vs. scale-up strain: Dual approvals created a mission-rich, well‑rewarded environment, but also meeting‑heavy days, long sprints, and evolving processes and communication. Candidates who relish speed and building will thrive; those seeking polished systems and predictable hours may struggle.

Evidence in Action

Launch Driven Mission Pride — Revuforj (revumenib) approval in November 2024 and Niktimvo (axatilimab‑csfr) approval in 2024/early 2025 signal commercial momentum and patient impact. This anchors pride and purpose, and reinforces perceived stability and growth for employees.
Equity Forward Total Rewards — Inducement option grants, plus broad equity and bonus eligibility, are documented compensation practices. They signal shared upside and competitiveness, improving attraction and retention for people who value ownership and performance-linked pay.

Positive Themes About Syndax Pharmaceuticals

Mission & Purpose: Two recently approved medicines and active launches provide a clear patient-focused mission and visible impact. Opportunities to build commercial franchises in oncology are portrayed as uniquely motivating.
Career Growth: Steep learning curves, cross-functional exposure, and rapid responsibility are common as commercial operations scale. A lean organization with access to senior leaders enables accelerated development.
Compensation: Pay and benefits are characterized as competitive, with generous perks and recognition programs. Equity and inducement grants are cited alongside standard health and bonus programs.

Considerations About Syndax Pharmaceuticals

Workload & Burnout: Long hours around launches, dense meeting calendars, and the need to self-manage boundaries are common in the shift from clinical to commercial. Work often intensifies during crunch periods with cross-functional dependencies.
Leadership Gaps: Communication can be uneven with perceived instability just below the C-suite. Disorganization and toxic dynamics have appeared during stressful periods and vary by team and manager.
Change Fatigue: Rapid growth, shifting priorities, and an HQ move alongside label expansions create persistent change. Remote-first coordination and evolving processes can amplify execution pressure.

NEW

What does AI tell candidates about your employer brand?

Get your free AI reputation report today.

See AI Report

These insights are generated using AI and may not reflect internal data or verified company information. They are intended solely for general informational purposes and should not be considered a definitive assessment of the company’s reputation. If you are a representative of this company, and would like this page to be removed, you may contact us via this form.